INVESTIGATIONS OF MECHANISMS OF BIOLOGICAL ACTIVATIONS, AND STRUCTURE-PROPERTY-ACTIVITY STUDIES IN VIVO AND IN VITRO
Main researcher
: RENDIĆ, SLOBODAN (40820) Assistants
MEDIĆ-ŠARIĆ, MARICA (74265)
JURIŠIĆ, BLAŽENKA (142755)
MALEŠ, ŽELJAN (142654)
PULJKO, DAHNA (900772)
Type of research: applied Duration from: 01/01/91. to 12/31/96. Papers on project (total): 84
Papers on project quoted in Current Contents: 12
Institution name: Farmaceutsko-biokemijski fakultet, Zagreb (6) Department/Institute: Department of pharmaceutical chemistry Address: A. Kovačića 1 City: 10000 - Zagreb, Croatia
Communication
Phone: 385 (01)448-516
Fax: 385 (01)445-117
Summary: Investigation of the mechanisms of biotransformations,
interactions with proteins, and biological activations of chemicals,
including environmental chemicals, chemicals used as explosives, and drugs
with a goal to determine biologically active metabolites in vitro and in
vivo. Development and methodological standardization of the procedures of
analysis and confirmation of drugs of abuse (stimulans such as are
mephentermine, mefenorex, amphetamine, and anabolic steroids testosterone,
stanozolol and metabolites) in the urine samples, development and
publication of the POSITION PAPER for the International Federation of
Clinical Chemistry. Investigations are focused on enzymatic reactions
catalyzed by the cytochrome P450 superfamily of enzymes in laboratory
animals and humans. Optimisation of the analytical procedures (TLC, HPLC,
GC, GC-MS) and of the reaction conditions is performed by using methods of
the numerical taxonomy and the theory of information. Following model
proteins and systems are used for study of the mechanisms of interactions
of environmenatal chemicals, chemicals used as explosives and drugs with
proteins and protein systems: humane serum albumin, cytochromes P450, and
other hemproteins (such as are peroxidases). Reactions kinetic is followed
by the stopped flow cryoscopic spectrometry. The compounds used for the
study are imidazole and furane drugs (H2-receptor antagonists),
enantiomeric compounds such as are enantiomers of a new antidiabetic drug
etomoxir, natural (testosterone, epitestosterone) and synthetic steroids
(stanozolol, metandienone, and endogenous compounds such are, for instance,
fatty acids). Structure-physicochemical properties (QSPR) and
structure-biological activity (QSAR) studies of the chemicals studied as
well as hydrophobic parameters (log P and RM) calcullated according to
Hansch and/or Rekker are used for correlation with different molecular
descriptors such as are W(G), X(G), J(G) and I(G).
Keywords: cytochrome(s) P450, CYP enzymes, peroxidases, drugs, chemicals, ligands, human serum albumune, binding, stereoselectivity, mechanisms of binding, QSAR, QSPR, analysis of, drugs, environmental chemicals, explosives, drugs of abuse, analysis, urine, position document
Research goals: The goal of this project is to study the mechanisms
of interactions of chemicals including environmental chemicals, explosives
and drugs, with biological macromolecules, with a goal to get better
insight to understanding of the mechanisms of biological effects
(therapeutic and toxic) as a consequence of such interactions. Therapeutic
as well as toxic properties of a chemical compoundmight be changed
influencing the activities of enzymes containing protoporphirine ring. In
these enzyme the ring as prostetic group (cytochromes P450 and
peroxidazes) represents actually the active site of the enzyme for
activation of molecular oxigen and/or the chemical. Such activations
results in mechanisms of toxicity. Following model compounds will be used:
phenylalkylamines, H2-receptor antagonists (cimetidine and ranitidine),
and steroid hormones, environmental chemicals (explosives). The model
compounds are important therapeutical agents and environmental
pollutants that ellicitsignificant toxic and side effects. These effects
are repeatedly shown to be connectedwith changed activity and/or the
content of the enzymes under study. Interactions of the compounds with
toxicologically important enzymes such as peroxidases should bring
additional information about possible mechanisms of interactions. The goal
is to get additional information for clinically important toxic reactions
following administration of the drugs. Also influence of environmental
chemicals such as are policyclic aromatic hydrocarbones and explosive
chemicals will be tested. Human serum albumin is aprincipal binding
protein in plasma for a number of drugs and endogenous compounds exerting
stereoselectivity of interaction with enantiomeric as well as with
prochiral compounds. Study of the binding of new drugs (enantiomers of
etomoxir) with HSA should reveal binding parameters of the racemate and of
theenantiomers, and to indicate possible clinical interactions with
endogenous compounds and exogenous drugs represented by stearic acid and
anabolic hormone stanozolol. Metabolic interactions on the level
ofcytochrome P450 following administration of endogenous steroid
testosterone as well as other anabolic synthetic compounds
(i.e.stanozolol) is under invesigation in both in vivo (in clinical
studies and following administration to rats) and in vitro condition. The
results should give answers about interactions on the level of
biosynthesis of endogenous steroids referring to testosterone and its
inactive isomer epitestosterone. Already preliminary results indicate
repressionof the biosynthesis of epitestosterone following testosterone
and synthetic steroids. The methodological approach to the analysis of
drugs in the urine samples and metabolites subject of the "Position Paper"
prepared by the expert group (see publications) for
InternationalFederation of Clinical Chemistry. Numerical taxonomy
foroptimisation of the analytical as well as reaction kinetic conditions
is under study for analysis of testosterone and other steroids and
metabolites. QSPR and QSAR studies are succesfully applied foranalysis the
biological activities of phenylalkylamines as well as other compounds
(see publications).
COOPERATION - INSTITUTIONS
Name of institution
: Clinical Pharmacology, Departments of
medicine and Pharmacology, University of California, UCLA Medical center Type of institution: University/Faculty Type of cooperation: Joint publishing of scientific papers City: 90024 - Los Angeles, USA
Name of institution
: Facul…t f—r Biologie, Universit…t Konstanz Type of institution: University/Faculty Type of cooperation: Systematic exchange of experts City: 7750 - Konstanz, Njemačka
Name of institution
: Byk Goulden, Konstanz Type of institution: Economical/Production Type of cooperation: Systematic exchange of information City: 7750 - Konstanz, Njemačka
Name of institution
: Pliva, Istraživački institut Type of institution: Economical/Production Type of cooperation: Joint publishing of scientific papers City: 10000 - Zagreb, Croatia
Name of institution
: Deutsche Sporthochschule, Institut f—r
Biochemie Type of institution: University/Faculty Type of cooperation: Systematic exchange of information City: 5000 - K•ln, Njemačka
Name of institution
: Institut Rudjer Bošković Type of institution: University/Faculty Type of cooperation: Joint publishing of scientific papers City: 10000 - Zagreb, Croatia
Name of institution
: Institute for molecular biophysics, Florida
State University Type of institution: University/Faculty Type of cooperation: Occasional exchange of experts City: 32306 - Tallahassee, USA
Name of institution
: GlaxoWellcome Research Institute Type of institution: Economical/Production Type of cooperation: Systematic exchange of information
Name of institution
: GlaxoWellcome Research and Development Type of institution: Economical/Production Type of cooperation: Systematic exchange of information City: SG12ODP - Ware, United Kingdom Other information about the project.